NEO · Neogenomics Inc · Executive Compensation

$17.99 +0.72 (+4.17%) At close · Oct 28 Q2 2026 earnings call transcript

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$2.22B

128.48M

Volume · Oct 28 2.58M Avg daily vol (3M) 2.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Tony Zook	Director and Chief Executive Officer	$601,539	—	$3,999,997	$3,998,235	$513,400	$13,921	$9,127,092
Warren Stone	Chief Commercial Officer	$630,069	$400,000	$2,249,994	$1,499,767	$275,000	$14,000	$5,068,830
Jeffrey Sherman	Chief Financial Officer	$603,731	$50,000	$2,250,000	$1,499,697	$264,000	$14,000	$4,681,428
Christopher Smith	Former Director and Former Chief Executive Officer	$310,962	—	$3,350,004	—	$155,754	$229,217	$4,045,937
Melody Harris	Former Chief Operations Officer and Former President, Oncology Data Solutions	$269,231	$152,329	$1,666,652	$912,848	—	$691,385	$3,692,445
Alicia Olivo	Executive Vice President, General Counsel and Business Development	$522,500	$75,000	$1,499,997	$749,848	$196,000	$6,654	$3,049,999
Gary Passman	Chief Culture Officer	$447,962	$75,000	$1,124,995	$624,876	$164,000	$6,362	$2,443,195

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Smith	Director and Chief Executive Officer	$1,036,539	—	$5,870,784	$2,826,614	$1,590,750	$13,800	$11,338,487
Jeffrey S. Sherman	Chief Financial Officer	$540,346	—	$1,588,566	$764,486	$575,211	$13,800	$3,482,409
Jeffrey Sherman	Chief Financial Officer	$540,346	—	$1,588,566	$764,486	$575,211	$13,800	$3,482,409
Warren Stone	Chief Commercial Officer	$562,516	—	$1,381,166	$665,274	$561,730	$13,800	$3,184,486
Melody Harris	Chief Operations Officer and President, Oncology Data Solutions	$559,975	—	$1,208,572	$582,430	$510,600	$13,800	$2,875,377
Vishal Sikri	President, Advanced Diagnostics	$246,208	—	$941,892	$457,379	—	$636,881	$2,282,360
Alicia Olivo	Executive Vice President, General Counsel and Business Development	$512,672	—	$863,357	$415,255	$431,775	$13,800	$2,236,859
Tony Zook	Director and Chief Executive Officer	—	—	—	—	—	—	—
Gary Passman	Chief Culture Officer	—	—	—	—	—	—	—

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Smith	Director and Chief Executive Officer	$1,000,000	—	$5,986,768	$2,816,870	$1,850,000	$12,308	$11,665,946
Melody Harris	Chief Operations Officer and President, Oncology Data Solutions	$525,000	—	$1,880,389	$1,413,551	$532,700	$342,585	$4,694,225
Jeffrey S. Sherman	Chief Financial Officer	$525,000	—	$1,619,944	$762,214	$627,000	$13,200	$3,547,358
Jeffrey Sherman	Chief Financial Officer	$525,000	—	$1,619,944	$762,214	$627,000	$13,200	$3,547,358
Warren Stone	Chief Commercial Officer	$525,000	—	$1,030,398	$563,383	$546,800	$343,669	$3,009,250
Vishal Sikri	President, Advanced Diagnostics	$528,635	—	$880,390	$414,251	$535,300	$13,200	$2,371,776
Tony Zook	Director and Chief Executive Officer	—	—	—	—	—	—	—
Gary Passman	Chief Culture Officer	—	—	—	—	—	—	—
Alicia Olivo	Executive Vice President, General Counsel and Business Development	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Smith	Director and Chief Executive Officer	$346,154	—	$7,600,000	$4,250,000	$455,438	$2,146,930	$14,798,522
Vishal Sikri	President, Advanced Diagnostics	$294,231	$500,000	$1,250,000	$1,250,000	$255,000	$12,750	$3,561,981
Jeffrey S. Sherman	Chief Financial Officer	$16,154	$250,000	$1,500,000	$1,500,000	—	—	$3,266,154
Jeffrey Sherman	Chief Financial Officer	$16,154	$250,000	$1,500,000	$1,500,000	—	—	$3,266,154
Warren Stone	Chief Commercial Officer	$40,385	$350,000	$1,000,000	$1,000,000	—	—	$2,390,385
Alicia Olivo	Executive Vice President, General Counsel and Business Development	—	—	—	—	—	—	—
Melody Harris	Chief Operations Officer and President, Oncology Data Solutions	—	—	—	—	—	—	—

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Melody Harris	President, Enterprise Operations	—	—	—	—	—	—	—
Christopher Smith	Director and Chief Executive Officer	—	—	—	—	—	—	—
Vishal Sikri	President, Advanced Diagnostics	—	—	—	—	—	—	—
Jeffrey Sherman	Chief Financial Officer	—	—	—	—	—	—	—
Warren Stone	President, Clinical Services	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Douglas M. VanOort	Chairman of the Board & Chief Executive Officer	$669,039	—	$990,000	$2,010,000	$450,000	$3,000	$4,122,039
Robert J. Shovlin	President of Clinical Services	$404,808	—	$247,500	$502,000	$140,000	$3,000	$1,297,308
Dr. Lawrence M. Weiss	Chief Medical Officer	$600,000	—	$165,000	$335,000	$185,000	—	$1,285,000
Douglas M. Brown	Chief Strategy and Corporate Development Officer	$346,154	—	$198,000	$402,000	$200,000	$100,000	$1,246,154
Kathryn B. McKenzie	Chief Financial Officer	$359,616	—	$165,000	$335,000	$175,000	—	$1,034,616
Sharon A. Virag	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Douglas M. VanOort	Chairman of the Board & Chief Executive Officer	$665,000	—	$742,507	$1,338,225	$900,000	$3,000	$3,648,732
Robert J. Shovlin	President of Clinical Services	$400,000	—	$214,502	$386,597	$280,000	$3,000	$1,284,099
Dr. Lawrence M. Weiss	Chief Medical Officer	$600,000	—	$115,503	$208,171	$260,000	—	$1,183,674
George A. Cardoza	President of Pharma Services	$380,000	—	$164,993	$297,381	$265,000	—	$1,107,374
Sharon A. Virag	Chief Financial Officer	$257,723	—	$214,502	$386,597	$182,823	—	$1,041,645
Kathryn B. McKenzie	Chief Financial Officer	$250,000	—	$44,551	$80,293	$150,000	—	$524,844
Douglas M. Brown	Chief Strategy and Corporate Development Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Douglas M. VanOort	Chairman of the Board & Chief Executive Officer	$641,923	—	$650,006	$1,278,290	$774,000	$3,000	$3,347,219
Robert J. Shovlin	President of Clinical Services	$375,385	—	—	$737,598	$212,756	$3,000	$1,328,739
Sharon A. Virag	Chief Financial Officer	$298,462	$120,000	—	$485,100	$190,000	—	$1,093,562
George A. Cardoza	President of Pharma Services	$370,000	—	—	$492,158	$194,364	—	$1,056,522
Dr. Lawrence M. Weiss	Chief Medical Officer	$571,519	$100,000	—	$152,100	$32,276	—	$855,895
Douglas M. Brown	Chief Strategy and Corporate Development Officer	—	—	—	—	—	—	—
Kathryn B. McKenzie	Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Douglas M. VanOort	Chairman of the Board & Chief Executive Officer	$616,346	—	$1,432,495	$1,231,667	$200,000	$3,000	$3,483,508
Robert J. Shovlin	President of Clinical Services	$350,000	—	$363,500	$492,667	$95,000	$3,000	$1,304,167
George A. Cardoza	President of Pharma Services	$352,692	—	$181,750	$492,667	$80,000	—	$1,107,109
Dr. Lawrence M. Weiss	Chief Medical Officer	—	—	—	—	—	—	—
Sharon A. Virag	Chief Financial Officer	—	—	—	—	—	—	—
Kathryn B. McKenzie	Vice President and Chief Accounting Officer (Principal Financial Officer)	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Michael Kelly	Lead Independent Director	Appointed	2027-01-04	2026-10-05
Tony Zook	Executive Chairman	Appointed	2027-01-04	2026-10-05
Warren Stone	member of the Board	Appointed	2027-01-04	2026-10-05
Warren Stone	Chief Executive Officer	Appointed	2027-01-04	2026-10-05
Carolyn S. Starrett	director	Appointed	2026-06-23	2026-06-25
Felicia Williams	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
David B. Perez	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Anthony P. Zook	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
John P. Kenny	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Michael A. Kelly	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Stephen M. Kanovsky	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Neil Gunn	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Marjorie C. Green	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Lynn A. Tetrault	member of the Board of Directors	Appointed	2026-05-21	2026-05-22
Abhishek Jain	Chief Financial Officer	Appointed	2026-03-02	2026-01-12
Jeffrey S. Sherman	Chief Financial Officer	Retired	2026-04-14	2026-01-12
Jack Kenny	member of the Board	Appointed	2026-01-01	2025-12-30
Dr. Alison L. Hannah	director	Resigned	2025-12-31	2025-12-30
Elizabeth Floegel	Board of Directors	Resigned	2025-08-05	2025-08-08
Marjorie C. Green	director	Appointed	2025-06-19	2025-06-24
David B. Perez	member of the Board of Directors	Appointed	2025-05-22	2025-05-27
Anthony P. Zook	member of the Board of Directors	Appointed	2025-05-22	2025-05-27
Felicia Williams	member of the Board of Directors	Appointed	2025-05-22	2025-05-27
Michael A. Kelly	member of the Board of Directors	Appointed	2025-05-22	2025-05-27
Stephen M. Kanovsky	member of the Board of Directors	Appointed	2025-05-22	2025-05-27

Leadership

Chris Smith CEO, Board Member
Christopher Smith CEO, Board Member
Tony Zook CEO, Chairman, Board Member
Warren Stone CEO, COO, Board Member
Douglas M. VanOort Chairman
Lynn A. Tetrault Chairman, Board Member
Jeffrey S. Sherman CFO
Jeffrey Sherman CFO
Melody Harris COO
Alicia Olivo General Counsel
Cynthia J. (Cindy) Dieter Chief Accounting Officer
Carolyn S. Starrett Board Member
David B. Perez Board Member
David Perez Board Member
Dr. Marjorie Green Board Member
Dr. Neil Gunn Board Member
Felicia Williams Board Member
Jack Kenny Board Member
John P. Kenny Board Member
Lynn Tetrault Board Member
Marjorie C. Green Board Member
Michael A. Kelly Board Member
Michael Kelly Board Member
Neil Gunn Board Member
Stephen Kanovsky Board Member
Stephen M. Kanovsky Board Member

Key facts CIK 1077183 CUSIP 64049M209 13F (30d) 57 filings 57 filers Visit website Investor relations